Discovery of orally bioavailable 1,3,4-trisubstituted 2-oxopiperazine-based melanocortin-4 receptor agonists as potential antiobesity agents. [electronic resource]
- Journal of medicinal chemistry Oct 2008
- 6055-66 p. digital
Publication Type: Journal Article
1520-4804
10.1021/jm800525p doi
Administration, Oral Animals Anti-Obesity Agents--chemistry Biological Availability Diet Disease Models, Animal Dogs Drug Design Drug Evaluation, Preclinical Eating--drug effects Male Molecular Conformation Obesity--drug therapy Piperazines--chemistry Rats Receptor, Melanocortin, Type 4--agonists Stereoisomerism